Sky View Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Sky View Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $486,744 - $540,453	-7,640 Reduced 91.68%	693 $94,000
Q1 2023 May 18, 2023	BUY	$65.71 - $74.53 $13,601 - $15,427	207 Added 2.55%	8,333 $578,000
Q4 2022 Feb 16, 2023	SELL	$68.48 - $81.09 $32,459 - $38,436	-474 Reduced 5.51%	8,126 $585,000
Q3 2022 Nov 16, 2022	BUY	$0.13 - $76.84 $161 - $95,665	1,245 Added 16.93%	8,600 $611,000
Q2 2022 Nov 15, 2022	BUY	$72.62 - $79.98 $203,699 - $224,343	2,805 Added 61.65%	7,355 $566,000
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $16,907 - $20,273	-275 Reduced 5.7%	4,550 $353,000
Q4 2021 Feb 18, 2022	BUY	$53.63 - $62.52 $69,879 - $81,463	1,303 Added 37.0%	4,825 $383,000
Q3 2021 Nov 16, 2021	BUY	$59.17 - $69.31 $10,295 - $12,059	174 Added 5.2%	3,522 $208,000
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $3,857 - $4,338	65 Added 1.98%	3,348 $211,000
Q4 2020 Mar 02, 2021	BUY	$57.74 - $65.43 $189,560 - $214,806	3,283 New	3,283 $204,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.